Progressive Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,503
Closed -$356K 54
2016
Q3
$356K Hold
4,503
0.33% 51
2016
Q2
$376K Buy
4,503
+202
+5% +$17.9K 0.36% 53
2016
Q1
$395K Hold
4,301
0.4% 53
2015
Q4
$435K Sell
4,301
-440
-9% -$45.8K 0.46% 50
2015
Q3
$466K Buy
4,741
+248
+6% +$27.5K 0.54% 46
2015
Q2
$526K Sell
4,493
-270
-6% -$29.5K 0.58% 44
2015
Q1
$467K Buy
+4,763
New +$484K 1.61% 36

Other funds holding GILD

Progressive Investment Management's GILD Position: Q4 2016 in Review

Progressive Investment Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 4,503 shares — an estimated $356K sold.

Progressive Investment Management first reported a position in GILD in Q1 2015 and held it in 7 quarters. The position peaked at $526K in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Progressive Investment Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Progressive Investment Management sold 4,503 Gilead Sciences shares in Q4 2016, an estimated $356K.
  • Progressive Investment Management first reported a position in Gilead Sciences in Q1 2015 and held it in 7 quarters.
  • Progressive Investment Management's Gilead Sciences position peaked at $526K in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Progressive Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.